US drug companies say $26bn opioid settlement will proceed
Al Jazeera
Companies say ‘enough’ US states joined a settlement resolving claims they fuelled the opioid epidemic, allowing it to move ahead.
Three large US drug distributors and drugmaker Johnson & Johnson will proceed with a proposed $26bn settlement resolving claims that they fuelled the opioid epidemic after “enough” states joined in, the companies said on Saturday. The companies had until Saturday to decide whether enough states back the $21bn proposed settlement with McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc and a $5bn agreement with J&J. The distributors said 42 states, five territories and Washington, DC, signed on to their agreement. The exact tally for J&J’s related deal was not immediately clear.
Vulnerable nations are seeking $1.3 trillion annually to deal with the damage caused by climate change and to adapt.
The city’s southern suburbs have been hit repeatedly in recent months
New York judge cancels a sentencing hearing previously scheduled for November 26 without setting a new date.
Many Haitian children face the stark choice of joining a gang or suffering from violence, poverty and hunger engulfing them.
Tapped to lead the Justice Department, Bondi is a former Florida attorney general and longtime Trump supporter.
The arrest warrants against Netanyahu and Gallant could lead to countries rethinking arms deals with Israel, experts say
Moscow says the Oreshnik, a nuclear-capable weapon, was used in an attack on Ukraine amid escalating tensions.
Police say a ‘suspected prohibited item’ was discovered in luggage in the facility’s south terminal.
The NGOs want the Netherlands to ban the export and transit of weapons, weapon parts, and dual-use items to Israel.
All the details about the biggest two weeks in chess as a young Indian grandmaster takes on the Chinese world champion.
South Korea’s national security adviser says North plans to use the weapons to defend its airspace over the capital.